Stock listing

N1BI34 Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: N1BI34 · BMFBOVESPA · BRL · BR

N1BI34:BMFBOVESPA represents Neurocrine Biosciences, Inc., a company dedicated to developing and commercializing innovative therapies for neurological and endocrine disorders. With a significant market capitalization of around $17.18 billion, Neurocrine focuses on advancing treatments that enhance patient outcomes. The company is actively engaged in addressing unmet medical needs, reflecting its commitment to improving healthcare in its field. Recent news and filings may provide further insights into its ongoing projects and market activities.

N1BI34:BMFBOVESPABRLBRUpdated July 24, 2026
Neurocrine Biosciences, Inc. logo
Ticker
N1BI34:BMFBOVESPA
Asset type
Stock
Market cap
$17.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
BMFBOVESPA
Currency
BRL

Neurocrine Biosciences, Inc. N1BI34:BMFBOVESPA stock context

N1BI34:BMFBOVESPA represents Neurocrine Biosciences, Inc., a company dedicated to developing and commercializing innovative therapies for neurological and endocrine disorders. With a significant market capitalization of around $17.18 billion, Neurocrine focuses on advancing treatments that enhance patient outcomes. The company is actively engaged in addressing unmet medical needs, reflecting its commitment to improving healthcare in its field. Recent news and filings may provide further insights into its ongoing projects and market activities.

Research Neurocrine Biosciences, Inc.

Alternate listings